SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-025612
Filing Date
2022-02-22
Accepted
2022-02-22 16:04:48
Documents
15
Period of Report
2022-02-18
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm226900d1_8k.htm   iXBRL 8-K 29613
2 EXHIBIT 3.1 tm226900d1_ex3-1.htm EX-3.1 150220
7 GRAPHIC tm226900d1_ex3-1img001.jpg GRAPHIC 1370
  Complete submission text file 0001104659-22-025612.txt   444047

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA abt-20220218.xsd EX-101.SCH 3380
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abt-20220218_def.xml EX-101.DEF 28560
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE abt-20220218_lab.xml EX-101.LAB 37746
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abt-20220218_pre.xml EX-101.PRE 26778
9 EXTRACTED XBRL INSTANCE DOCUMENT tm226900d1_8k_htm.xml XML 5569
Mailing Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500
Business Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500 2246676100
ABBOTT LABORATORIES (Filer) CIK: 0000001800 (see all company filings)

IRS No.: 360698440 | State of Incorp.: IL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-02189 | Film No.: 22658030
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences